BLUEBASE FOUNDATION
to advance such charitable purposes (according to the law of England and Wales) as the trustees seefit from time to time for the public benefit by making grants and awards to organisations for the publicbenefit particularly, but not limited to, Hungary and in and around the West Midlands
Financial health, per its FY2026 accounts
The accounts state that the charity received over £2 million in donations and held total unrestricted funds of £3,006,101 at the end of the year. The trustees report that the charity has adequate resources to continue in operation for the foreseeable future and identified no material uncertainties regarding its going concern status.
What the accounts disclose
“The Charity’s intention is to hold reserves and use when requests for grants or awards by Charities/Non-Profit organisations and amateur sports clubs are approved by the Trustees and for the continual funding of the Hungarian Hospice when required.” — page 7
“During the year, the Charity received donations of £66,750 (2025: £Nil) from Revelan Group Ltd, a Company in which Trustee Nicholas Megyesi-Schwartz is a director. At 31 March 2026, no amounts were outstanding (2025: £Nil). During the year, the Charity received donations of £1,950,000 (2025: £Nil) from Bluebase Limited, a Company in which Trustee Nicholas Megyesi-Schwartz is a director. At 31 March 2026, no amounts were outstanding (2025: £Nil). The Charity holds a programme-related investment in Megyesi-Schwartz Hospice Non-profit Ltd (Hungary), an affiliated Charitable organisation of which Trustees Nicholas Francis Megyesi-Schwartz and Diána Sarolta Megyesi-Schwartz are directors. The investment is held primarily to further the Charity's Charitable objectives by supporting the acquisition, development and operation of hospice facilities in Pécs, Hungary. During the year, the previous loan receivable was reclassified as a programme-related investments following a review of its purpose and terms. On 14 May 2026, the Trustees resolved to waive accrued interest of £106,875 and amend the investment terms so that no further interest accrues from 1 January 2026. The programme-related investments had a carrying value of £1,277,213 at 31 March 2026 (2025: loan receivable £954,945). During the year the Charity advanced a further £277,755 to the Hungarian hospice project through its programme-related investments. There was also a foreign exchange movement on programme-related investments of £44,513 see note 10. The investment is secured by a mortgage over the hospice property. No other related party transactions took place during the year other than Trustee remuneration and expenses disclosed in note 9.” — page 28
Structured financials (annual return, FY ending 31/03/2026)
Trustees
- Nicholas Megyesi-Schwartzchair
- Benjamin Voss-Wood
- Trevor Payton
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2026 | £2.1m | £173k |
| 31/03/2025 | £53k | £131k |
| 31/03/2024 | £1.3m | £66k |
Common questions
Is BLUEBASE FOUNDATION financially healthy?
Per its FY2026 accounts: The accounts state that the charity received over £2 million in donations and held total unrestricted funds of £3,006,101 at the end of the year. The trustees report that the charity has adequate resources to continue in operation for the foreseeable future and identified no material uncertainties regarding its going concern status. Its FY2026 accounts were audited by MHA.